ITGA2 and glioblastoma: To translate the use of ITGA2 into GBM-targeted therapy, we developed an ITGA2 antibody-directed liposome (ITGA2-Dox-LP) to selectively deliver doxorubicin, a standard-of-care chemodrug, to GBM cells.